{
  "Version": 76,
  "Individuals": [
    {
      "Name": "European (P-gp modified, CYP3A4 36 h) - Villikka 1997",
      "Seed": 17189110,
      "OriginData": {
        "CalculationMethods": [
          "SurfaceAreaPlsInt_VAR1",
          "Body surface area - Mosteller"
        ],
        "Species": "Human",
        "Population": "European_ICRP_2002",
        "Gender": "MALE",
        "Age": {
          "Value": 30.0,
          "Unit": "year(s)"
        }
      },
      "Parameters": [
        {
          "Path": "Organism|Liver|EHC continuous fraction",
          "Value": 1.0,
          "ValueOrigin": {
            "Source": "Unknown"
          }
        }
      ],
      "Molecules": [
        {
          "Name": "CYP3A4",
          "Type": "Enzyme",
          "MembraneLocation": "Apical",
          "TissueLocation": "Intracellular",
          "IntracellularVascularEndoLocation": "Endosomal",
          "Expression": [
            {
              "Name": "Brain",
              "Value": 0.0041682898325
            },
            {
              "Name": "Gonads",
              "Value": 0.00078691079081
            },
            {
              "Name": "Kidney",
              "Value": 0.0053603428126
            },
            {
              "Name": "Periportal",
              "Value": 1.0
            },
            {
              "Name": "Pericentral",
              "Value": 1.0
            },
            {
              "Name": "Lung",
              "Value": 0.00042695753798
            },
            {
              "Name": "SmallIntestine",
              "Value": 0.0727697702
            },
            {
              "Name": "Duodenum",
              "Value": 0.0727697702
            },
            {
              "Name": "UpperJejunum",
              "Value": 0.0727697702
            },
            {
              "Name": "LowerJejunum",
              "Value": 0.0727697702
            },
            {
              "Name": "UpperIleum",
              "Value": 0.0727697702
            },
            {
              "Name": "LowerIleum",
              "Value": 0.0727697702
            }
          ],
          "Ontogeny": {
            "Name": "CYP3A4"
          },
          "Parameters": [
            {
              "Name": "Reference concentration",
              "Value": 4.8,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "ParameterIdentification",
                "Method": "ParameterIdentification",
                "Description": "Value updated from 'Parameter Identification 1' on 2019-11-29 10:17"
              }
            },
            {
              "Name": "t1/2 (liver)",
              "Value": 36.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Name": "AADAC",
          "Type": "Enzyme",
          "MembraneLocation": "Apical",
          "TissueLocation": "Intracellular",
          "IntracellularVascularEndoLocation": "Endosomal",
          "Expression": [
            {
              "Name": "BloodCells",
              "Value": 3.9102564103E-05
            },
            {
              "Name": "Plasma",
              "Value": 3.9102564103E-05
            },
            {
              "Name": "Bone",
              "Value": 4.8717948718E-05
            },
            {
              "Name": "Brain",
              "Value": 3.9743589744E-05
            },
            {
              "Name": "Gonads",
              "Value": 0.0011923076923
            },
            {
              "Name": "Heart",
              "Value": 0.0026602564103
            },
            {
              "Name": "Kidney",
              "Value": 5.7051282051E-05
            },
            {
              "Name": "Periportal",
              "Value": 1.0
            },
            {
              "Name": "Pericentral",
              "Value": 1.0
            },
            {
              "Name": "Lung",
              "Value": 0.0269230769
            },
            {
              "Name": "Muscle",
              "Value": 0.00020833333333
            },
            {
              "Name": "Pancreas",
              "Value": 0.1474358974
            },
            {
              "Name": "Spleen",
              "Value": 0.00037115384615
            },
            {
              "Name": "Stomach",
              "Value": 0.0775641026
            },
            {
              "Name": "SmallIntestine",
              "Value": 0.2544871795
            },
            {
              "Name": "LargeIntestine",
              "Value": 0.00010384615385
            },
            {
              "Name": "Duodenum",
              "Value": 0.2544871795
            },
            {
              "Name": "UpperJejunum",
              "Value": 0.2544871795
            },
            {
              "Name": "LowerJejunum",
              "Value": 0.2544871795
            },
            {
              "Name": "UpperIleum",
              "Value": 0.2544871795
            },
            {
              "Name": "LowerIleum",
              "Value": 0.2544871795
            },
            {
              "Name": "ColonAscendens",
              "Value": 0.00010384615385
            },
            {
              "Name": "ColonTransversum",
              "Value": 0.00010384615385
            },
            {
              "Name": "ColonDescendens",
              "Value": 0.00010384615385
            },
            {
              "Name": "ColonSigmoid",
              "Value": 0.00010384615385
            }
          ]
        },
        {
          "Name": "P-gp",
          "Type": "Transporter",
          "TransportType": "Efflux",
          "Expression": [
            {
              "Name": "Bone",
              "MembraneLocation": "Basolateral",
              "Value": 0.0341950646
            },
            {
              "Name": "Brain",
              "MembraneLocation": "BloodBrainBarrier",
              "Value": 0.1072855464
            },
            {
              "Name": "Gonads",
              "MembraneLocation": "Basolateral",
              "Value": 0.024559342
            },
            {
              "Name": "Heart",
              "MembraneLocation": "Basolateral",
              "Value": 0.059106933
            },
            {
              "Name": "Kidney",
              "MembraneLocation": "Apical",
              "Value": 1.0
            },
            {
              "Name": "Periportal",
              "MembraneLocation": "Apical",
              "Value": 0.2702702703
            },
            {
              "Name": "Pericentral",
              "MembraneLocation": "Apical",
              "Value": 0.2702702703
            },
            {
              "Name": "Lung",
              "MembraneLocation": "Basolateral",
              "Value": 0.0927144536
            },
            {
              "Name": "Muscle",
              "MembraneLocation": "Basolateral",
              "Value": 0.0180963572
            },
            {
              "Name": "Pancreas",
              "MembraneLocation": "Basolateral",
              "Value": 0.0200940071
            },
            {
              "Name": "Spleen",
              "MembraneLocation": "Basolateral",
              "Value": 0.1047003525
            },
            {
              "Name": "Stomach",
              "MembraneLocation": "Basolateral",
              "Value": 0.0367802585
            },
            {
              "Name": "SmallIntestine",
              "MembraneLocation": "Basolateral",
              "Value": 0.3960047004
            },
            {
              "Name": "LargeIntestine",
              "MembraneLocation": "Basolateral",
              "Value": 0.1562867215
            },
            {
              "Name": "Duodenum",
              "MembraneLocation": "Apical",
              "Value": 1.41
            },
            {
              "Name": "UpperJejunum",
              "MembraneLocation": "Apical",
              "Value": 1.41
            },
            {
              "Name": "LowerJejunum",
              "MembraneLocation": "Apical",
              "Value": 1.41
            },
            {
              "Name": "UpperIleum",
              "MembraneLocation": "Apical",
              "Value": 1.41
            },
            {
              "Name": "LowerIleum",
              "MembraneLocation": "Apical",
              "Value": 1.41
            },
            {
              "Name": "ColonAscendens",
              "MembraneLocation": "Apical",
              "Value": 0.56
            },
            {
              "Name": "ColonTransversum",
              "MembraneLocation": "Apical",
              "Value": 0.56
            },
            {
              "Name": "ColonDescendens",
              "MembraneLocation": "Apical",
              "Value": 0.56
            },
            {
              "Name": "ColonSigmoid",
              "MembraneLocation": "Apical",
              "Value": 0.56
            }
          ],
          "Ontogeny": {
            "Name": "P-gp",
            "Table": {
              "Name": "TableFormula",
              "Percentile": 0.0,
              "DistributionMetaData": [
                {
                  "Mean": 1E-14,
                  "Deviation": 1.6,
                  "Distribution": "LogNormal"
                },
                {
                  "Mean": 1.915059E-05,
                  "Deviation": 1.6,
                  "Distribution": "LogNormal"
                },
                {
                  "Mean": 5.486795E-05,
                  "Deviation": 1.6,
                  "Distribution": "LogNormal"
                },
                {
                  "Mean": 0.0001571905,
                  "Deviation": 1.6,
                  "Distribution": "LogNormal"
                },
                {
                  "Mean": 0.0004502473,
                  "Deviation": 1.6,
                  "Distribution": "LogNormal"
                },
                {
                  "Mean": 0.001288958,
                  "Deviation": 1.6,
                  "Distribution": "LogNormal"
                },
                {
                  "Mean": 0.00368424,
                  "Deviation": 1.6,
                  "Distribution": "LogNormal"
                },
                {
                  "Mean": 0.01048397,
                  "Deviation": 1.6,
                  "Distribution": "LogNormal"
                },
                {
                  "Mean": 0.02946235,
                  "Deviation": 1.6,
                  "Distribution": "LogNormal"
                },
                {
                  "Mean": 0.0800178,
                  "Deviation": 1.6,
                  "Distribution": "LogNormal"
                },
                {
                  "Mean": 0.1994918,
                  "Deviation": 1.6,
                  "Distribution": "LogNormal"
                },
                {
                  "Mean": 0.4165768,
                  "Deviation": 1.6,
                  "Distribution": "LogNormal"
                },
                {
                  "Mean": 0.6716791,
                  "Deviation": 1.6,
                  "Distribution": "LogNormal"
                },
                {
                  "Mean": 0.8542612,
                  "Deviation": 1.6,
                  "Distribution": "LogNormal"
                },
                {
                  "Mean": 0.943803,
                  "Deviation": 1.6,
                  "Distribution": "LogNormal"
                },
                {
                  "Mean": 0.9796414,
                  "Deviation": 1.6,
                  "Distribution": "LogNormal"
                },
                {
                  "Mean": 0.992799,
                  "Deviation": 1.6,
                  "Distribution": "LogNormal"
                },
                {
                  "Mean": 0.9974749,
                  "Deviation": 1.6,
                  "Distribution": "LogNormal"
                },
                {
                  "Mean": 0.9991173,
                  "Deviation": 1.6,
                  "Distribution": "LogNormal"
                },
                {
                  "Mean": 0.9996917,
                  "Deviation": 1.6,
                  "Distribution": "LogNormal"
                },
                {
                  "Mean": 0.9998924,
                  "Deviation": 1.6,
                  "Distribution": "LogNormal"
                },
                {
                  "Mean": 0.9999624,
                  "Deviation": 1.6,
                  "Distribution": "LogNormal"
                },
                {
                  "Mean": 0.9999869,
                  "Deviation": 1.6,
                  "Distribution": "LogNormal"
                },
                {
                  "Mean": 1.0,
                  "Deviation": 1.6,
                  "Distribution": "LogNormal"
                }
              ],
              "XName": "Postmenstrual age",
              "XDimension": "Age in years",
              "XUnit": "year(s)",
              "YName": "P-gp",
              "YDimension": "Fraction",
              "UseDerivedValues": false,
              "Points": [
                {
                  "X": 0.0,
                  "Y": 1E-14,
                  "RestartSolver": false
                },
                {
                  "X": 0.08333334,
                  "Y": 1.915059E-05,
                  "RestartSolver": false
                },
                {
                  "X": 0.1666667,
                  "Y": 5.486795E-05,
                  "RestartSolver": false
                },
                {
                  "X": 0.25,
                  "Y": 0.0001571905,
                  "RestartSolver": false
                },
                {
                  "X": 0.3333333,
                  "Y": 0.0004502473,
                  "RestartSolver": false
                },
                {
                  "X": 0.4166667,
                  "Y": 0.001288958,
                  "RestartSolver": false
                },
                {
                  "X": 0.5,
                  "Y": 0.00368424,
                  "RestartSolver": false
                },
                {
                  "X": 0.5833333,
                  "Y": 0.01048397,
                  "RestartSolver": false
                },
                {
                  "X": 0.6666667,
                  "Y": 0.02946235,
                  "RestartSolver": false
                },
                {
                  "X": 0.75,
                  "Y": 0.0800178,
                  "RestartSolver": false
                },
                {
                  "X": 0.8333333,
                  "Y": 0.1994918,
                  "RestartSolver": false
                },
                {
                  "X": 0.9166667,
                  "Y": 0.4165768,
                  "RestartSolver": false
                },
                {
                  "X": 1.0,
                  "Y": 0.6716791,
                  "RestartSolver": false
                },
                {
                  "X": 1.083333,
                  "Y": 0.8542612,
                  "RestartSolver": false
                },
                {
                  "X": 1.166667,
                  "Y": 0.943803,
                  "RestartSolver": false
                },
                {
                  "X": 1.25,
                  "Y": 0.9796414,
                  "RestartSolver": false
                },
                {
                  "X": 1.333333,
                  "Y": 0.992799,
                  "RestartSolver": false
                },
                {
                  "X": 1.416667,
                  "Y": 0.9974749,
                  "RestartSolver": false
                },
                {
                  "X": 1.5,
                  "Y": 0.9991173,
                  "RestartSolver": false
                },
                {
                  "X": 1.583333,
                  "Y": 0.9996917,
                  "RestartSolver": false
                },
                {
                  "X": 1.666667,
                  "Y": 0.9998924,
                  "RestartSolver": false
                },
                {
                  "X": 1.75,
                  "Y": 0.9999624,
                  "RestartSolver": false
                },
                {
                  "X": 1.833333,
                  "Y": 0.9999869,
                  "RestartSolver": false
                },
                {
                  "X": 3.333333,
                  "Y": 1.0,
                  "RestartSolver": false
                }
              ]
            }
          },
          "Parameters": [
            {
              "Name": "Reference concentration",
              "Value": 1.41,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Name": "OATP1B1",
          "Type": "Transporter",
          "TransportType": "Influx",
          "Expression": [
            {
              "Name": "Brain",
              "MembraneLocation": "BloodBrainBarrier",
              "Value": 0.00014166666667
            },
            {
              "Name": "Gonads",
              "MembraneLocation": "Basolateral",
              "Value": 0.0141666667
            },
            {
              "Name": "Heart",
              "MembraneLocation": "Basolateral",
              "Value": 0.0008253968254
            },
            {
              "Name": "Periportal",
              "MembraneLocation": "Basolateral",
              "Value": 1.0
            },
            {
              "Name": "Pericentral",
              "MembraneLocation": "Basolateral",
              "Value": 1.0
            },
            {
              "Name": "Lung",
              "MembraneLocation": "Basolateral",
              "Value": 4.0079365079E-05
            },
            {
              "Name": "Muscle",
              "MembraneLocation": "Basolateral",
              "Value": 0.00064682539683
            }
          ]
        },
        {
          "Name": "ATP1A2",
          "Type": "OtherProtein",
          "MembraneLocation": "Apical",
          "TissueLocation": "ExtracellularMembrane",
          "IntracellularVascularEndoLocation": "Endosomal",
          "Expression": [
            {
              "Name": "Bone",
              "Value": 0.0062154033171
            },
            {
              "Name": "Brain",
              "Value": 1.0
            },
            {
              "Name": "Gonads",
              "Value": 0.0508741242
            },
            {
              "Name": "Heart",
              "Value": 0.3179118843
            },
            {
              "Name": "Kidney",
              "Value": 0.0158938619
            },
            {
              "Name": "Periportal",
              "Value": 0.0223784807
            },
            {
              "Name": "Pericentral",
              "Value": 0.0223784807
            },
            {
              "Name": "Lung",
              "Value": 0.0272345453
            },
            {
              "Name": "Muscle",
              "Value": 0.7034193524
            },
            {
              "Name": "Pancreas",
              "Value": 0.0073903254795
            },
            {
              "Name": "Skin",
              "Value": 0.0389467988
            },
            {
              "Name": "Spleen",
              "Value": 0.0103243118
            },
            {
              "Name": "Stomach",
              "Value": 0.0309435884
            },
            {
              "Name": "SmallIntestine",
              "Value": 0.0501579923
            },
            {
              "Name": "LargeIntestine",
              "Value": 0.0786998764
            },
            {
              "Name": "Duodenum",
              "Value": 0.0501579923
            },
            {
              "Name": "UpperJejunum",
              "Value": 0.0501579923
            },
            {
              "Name": "LowerJejunum",
              "Value": 0.0501579923
            },
            {
              "Name": "UpperIleum",
              "Value": 0.0501579923
            },
            {
              "Name": "LowerIleum",
              "Value": 0.0501579923
            },
            {
              "Name": "ColonAscendens",
              "Value": 0.0786998764
            },
            {
              "Name": "ColonTransversum",
              "Value": 0.0786998764
            },
            {
              "Name": "ColonDescendens",
              "Value": 0.0786998764
            },
            {
              "Name": "ColonSigmoid",
              "Value": 0.0786998764
            }
          ],
          "Parameters": [
            {
              "Name": "Reference concentration",
              "Value": 0.47661714,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Name": "UGT1A4",
          "Type": "Enzyme",
          "MembraneLocation": "Apical",
          "TissueLocation": "Intracellular",
          "IntracellularVascularEndoLocation": "Endosomal",
          "Expression": [
            {
              "Name": "Periportal",
              "Value": 1.0
            },
            {
              "Name": "Pericentral",
              "Value": 1.0
            }
          ],
          "Ontogeny": {
            "Name": "UGT1A4"
          },
          "Parameters": [
            {
              "Name": "Reference concentration",
              "Value": 2.32,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Name": "GABRG2",
          "Type": "OtherProtein",
          "MembraneLocation": "Apical",
          "TissueLocation": "ExtracellularMembrane",
          "IntracellularVascularEndoLocation": "Endosomal",
          "Expression": [
            {
              "Name": "Brain",
              "Value": 1.0
            }
          ],
          "Parameters": [
            {
              "Name": "Reference concentration",
              "Value": 1.0877710492,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ]
    }
  ],
  "Compounds": [
    {
      "Name": "Rifampicin",
      "IsSmallMolecule": true,
      "PlasmaProteinBindingPartner": "Albumin",
      "Lipophilicity": [
        {
          "Name": "Optimized",
          "Parameters": [
            {
              "Name": "Lipophilicity",
              "Value": 2.5,
              "Unit": "Log Units",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "ParameterIdentification",
                "Description": "Hanke et al. 2018"
              }
            }
          ]
        },
        {
          "Name": "DrugBank logP",
          "IsDefault": false,
          "Parameters": [
            {
              "Name": "Lipophilicity",
              "Value": 2.7,
              "Unit": "Log Units"
            }
          ]
        }
      ],
      "FractionUnbound": [
        {
          "Name": "Templeton 2011",
          "Species": "Human",
          "Parameters": [
            {
              "Name": "Fraction unbound (plasma, reference value)",
              "Value": 17.0,
              "Unit": "%",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "Other",
                "Description": "Templeton 2011 (equilibrium dialysis)"
              }
            }
          ]
        },
        {
          "Name": "Baneyx 2013",
          "IsDefault": false,
          "Species": "Human",
          "Parameters": [
            {
              "Name": "Fraction unbound (plasma, reference value)",
              "Value": 16.0,
              "Unit": "%"
            }
          ]
        },
        {
          "Name": "Boman 1974",
          "IsDefault": false,
          "Species": "Human",
          "Parameters": [
            {
              "Name": "Fraction unbound (plasma, reference value)",
              "Value": 11.0,
              "Unit": "%"
            }
          ]
        }
      ],
      "Solubility": [
        {
          "Name": "Aqueous solubility",
          "Parameters": [
            {
              "Name": "Solubility at reference pH",
              "Value": 2800.0,
              "Unit": "mg/l",
              "ValueOrigin": {
                "Source": "Database",
                "Description": "DrugBank"
              }
            },
            {
              "Name": "Reference pH",
              "Value": 7.0,
              "ValueOrigin": {
                "Source": "Database",
                "Description": "DrugBank"
              }
            }
          ]
        },
        {
          "Name": "FaSSIF",
          "IsDefault": false,
          "Parameters": [
            {
              "Name": "Solubility at reference pH",
              "Value": 450.0,
              "Unit": "mg/l"
            },
            {
              "Name": "Reference pH",
              "Value": 6.5
            }
          ]
        },
        {
          "Name": "FeSSIF",
          "IsDefault": false,
          "Parameters": [
            {
              "Name": "Solubility at reference pH",
              "Value": 1600.0,
              "Unit": "mg/l"
            },
            {
              "Name": "Reference pH",
              "Value": 5.0
            }
          ]
        },
        {
          "Name": "Optimized",
          "IsDefault": false,
          "Parameters": [
            {
              "Name": "Solubility at reference pH",
              "Value": 1211.88,
              "Unit": "mg/l"
            },
            {
              "Name": "Reference pH",
              "Value": 7.0
            }
          ]
        }
      ],
      "IntestinalPermeability": [
        {
          "Name": "Optimized",
          "Parameters": [
            {
              "Name": "Specific intestinal permeability (transcellular)",
              "Value": 1.24E-05,
              "Unit": "cm/min",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "ParameterIdentification",
                "Description": "Hanke et al. 2018"
              }
            }
          ]
        }
      ],
      "PkaTypes": [
        {
          "Type": "Base",
          "Pka": 7.9,
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Type": "Acid",
          "Pka": 1.7,
          "ValueOrigin": {
            "Source": "Unknown"
          }
        }
      ],
      "Processes": [
        {
          "InternalName": "MetabolizationSpecific_MM",
          "DataSource": "Nakajima 2011",
          "Molecule": "AADAC",
          "Parameters": [
            {
              "Name": "Enzyme concentration",
              "Value": 1.0,
              "Unit": "µmol/l"
            },
            {
              "Name": "Vmax",
              "Value": 6.5,
              "Unit": "µmol/l/min"
            },
            {
              "Name": "Km",
              "Value": 195.1,
              "Unit": "µmol/l"
            },
            {
              "Name": "kcat",
              "Value": 9.865,
              "Unit": "1/min",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "ParameterIdentification",
                "Description": "Hanke et al. 2018"
              }
            }
          ]
        },
        {
          "InternalName": "ActiveTransportSpecific_MM",
          "DataSource": "Collett 2004",
          "Molecule": "P-gp",
          "Parameters": [
            {
              "Name": "Transporter concentration",
              "Value": 60.0,
              "Unit": "nmol/l"
            },
            {
              "Name": "Vmax",
              "Value": 2.87,
              "Unit": "µmol/l/min"
            },
            {
              "Name": "Km",
              "Value": 55.0,
              "Unit": "µmol/l"
            },
            {
              "Name": "kcat",
              "Value": 0.6088,
              "Unit": "1/min",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "ParameterIdentification",
                "Description": "Hanke et al. 2018"
              }
            }
          ]
        },
        {
          "InternalName": "ActiveTransportSpecific_MM",
          "DataSource": "Tirona 2003",
          "Molecule": "OATP1B1",
          "Parameters": [
            {
              "Name": "Transporter concentration",
              "Value": 109.6,
              "Unit": "µmol/l"
            },
            {
              "Name": "Vmax",
              "Value": 0.372,
              "Unit": "µmol/l/min"
            },
            {
              "Name": "Km",
              "Value": 1.5,
              "Unit": "µmol/l"
            },
            {
              "Name": "kcat",
              "Value": 7.796,
              "Unit": "1/min",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "ParameterIdentification",
                "Description": "Hanke et al. 2018"
              }
            }
          ]
        },
        {
          "InternalName": "GlomerularFiltration",
          "DataSource": "GFR",
          "Species": "Human",
          "Parameters": [
            {
              "Name": "GFR fraction",
              "Value": 1.0,
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "Assumption",
                "Description": "Hanke et al. 2018"
              }
            }
          ]
        },
        {
          "InternalName": "CompetitiveInhibition",
          "DataSource": "Kajosaari 2005",
          "Molecule": "CYP3A4",
          "Parameters": [
            {
              "Name": "Ki",
              "Value": 18.5,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Publication",
                "Description": "Kajosaari et al. 2005"
              }
            }
          ]
        },
        {
          "InternalName": "CompetitiveInhibition",
          "DataSource": "Reitman 2011",
          "Molecule": "P-gp",
          "Parameters": [
            {
              "Name": "Ki",
              "Value": 169.0,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "Assumption",
                "Description": "Reitman 2011 (IC50 = Ki (169 µM / (1+ (0.1 µM / 177 µM) )"
              }
            }
          ]
        },
        {
          "InternalName": "Induction",
          "DataSource": "Templeton 2011",
          "Molecule": "CYP3A4",
          "Parameters": [
            {
              "Name": "EC50",
              "Value": 0.34,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Publication",
                "Description": "Templeton 2011 (weighted mean for FHH)"
              }
            },
            {
              "Name": "Emax",
              "Value": 9.0,
              "ValueOrigin": {
                "Source": "Publication",
                "Description": "Templeton 2011 (weighted mean for FHH)"
              }
            }
          ]
        },
        {
          "InternalName": "Induction",
          "DataSource": "Greiner 1999",
          "Molecule": "P-gp",
          "Parameters": [
            {
              "Name": "EC50",
              "Value": 0.34,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "Assumption",
                "Description": "Hanke et al. 2018"
              }
            },
            {
              "Name": "Emax",
              "Value": 2.5,
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "Assumption",
                "Description": "Greiner et al. 1999"
              }
            }
          ]
        },
        {
          "InternalName": "Induction",
          "DataSource": "Dixit 2007",
          "Molecule": "OATP1B1",
          "Parameters": [
            {
              "Name": "EC50",
              "Value": 0.34,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "Assumption",
                "Description": "Hanke et al. 2018"
              }
            },
            {
              "Name": "Emax",
              "Value": 0.383,
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "ParameterIdentification",
                "Description": "Hanke et al. 2018"
              }
            }
          ]
        },
        {
          "InternalName": "Induction",
          "DataSource": "Assumed",
          "Molecule": "AADAC",
          "Parameters": [
            {
              "Name": "EC50",
              "Value": 0.34,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "Assumption",
                "Description": "Hanke et al. 2018"
              }
            },
            {
              "Name": "Emax",
              "Value": 0.985,
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "ParameterIdentification",
                "Description": "Hanke et al. 2018"
              }
            }
          ]
        }
      ],
      "CalculationMethods": [
        "Cellular partition coefficient method - Rodgers and Rowland",
        "Cellular permeability - PK-Sim Standard"
      ],
      "Parameters": [
        {
          "Name": "Molecular weight",
          "Value": 822.94,
          "Unit": "g/mol"
        }
      ]
    },
    {
      "Name": "Triazolam",
      "IsSmallMolecule": true,
      "Lipophilicity": [
        {
          "Name": "Optimized",
          "Parameters": [
            {
              "Name": "Lipophilicity",
              "Value": 1.897007419,
              "Unit": "Log Units",
              "ValueOrigin": {
                "Source": "ParameterIdentification",
                "Method": "ParameterIdentification",
                "Description": "Value updated from 'IV + Oral' on 2018-11-13 16:52"
              }
            }
          ]
        }
      ],
      "FractionUnbound": [
        {
          "Name": "Measurement",
          "Species": "Human",
          "Parameters": [
            {
              "Name": "Fraction unbound (plasma, reference value)",
              "Value": 0.174,
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "InVivo",
                "Description": "PMID: 3360971"
              }
            }
          ]
        }
      ],
      "Solubility": [
        {
          "Name": "Measurement",
          "Parameters": [
            {
              "Name": "Solubility at reference pH",
              "Value": 4.53,
              "Unit": "mg/l",
              "ValueOrigin": {
                "Source": "Unknown",
                "Description": "drugbank.ca"
              }
            },
            {
              "Name": "Reference pH",
              "Value": 7.0,
              "ValueOrigin": {
                "Source": "Unknown",
                "Description": "drugbank.ca"
              }
            }
          ]
        }
      ],
      "IntestinalPermeability": [
        {
          "Name": "Optimized",
          "Parameters": [
            {
              "Name": "Specific intestinal permeability (transcellular)",
              "Value": 7.0220146601E-05,
              "Unit": "cm/min",
              "ValueOrigin": {
                "Source": "ParameterIdentification",
                "Method": "ParameterIdentification",
                "Description": "Value updated from 'IV + Oral' on 2018-11-13 16:52"
              }
            }
          ]
        }
      ],
      "PkaTypes": [
        {
          "Type": "Base",
          "Pka": 1.52,
          "ValueOrigin": {
            "Source": "Unknown"
          }
        }
      ],
      "Processes": [
        {
          "InternalName": "MetabolizationLiverMicrosomes_MM",
          "DataSource": "alpha-OH pathway",
          "Molecule": "CYP3A4",
          "Parameters": [
            {
              "Name": "In vitro Vmax for liver microsomes",
              "Value": 2.36,
              "Unit": "nmol/min/mg mic. protein",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "InVitro",
                "Description": "PMID: 8632299"
              }
            },
            {
              "Name": "Km",
              "Value": 74.2,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "InVitro",
                "Description": "PMID: 8632299"
              }
            },
            {
              "Name": "kcat",
              "Value": 4.0317206142,
              "Unit": "1/min",
              "ValueOrigin": {
                "Source": "ParameterIdentification",
                "Method": "ParameterIdentification",
                "Description": "Value updated from 'IV + Oral' on 2018-11-13 16:52"
              }
            }
          ]
        },
        {
          "InternalName": "MetabolizationLiverMicrosomes_MM",
          "DataSource": "4-OH pathway",
          "Molecule": "CYP3A4",
          "Parameters": [
            {
              "Name": "In vitro Vmax for liver microsomes",
              "Value": 10.27,
              "Unit": "nmol/min/mg mic. protein",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "InVitro",
                "Description": "PMID: 8632299"
              }
            },
            {
              "Name": "Km",
              "Value": 305.0,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "InVitro",
                "Description": "PMID: 8632299"
              }
            },
            {
              "Name": "kcat",
              "Value": 17.5448180963,
              "Unit": "1/min",
              "ValueOrigin": {
                "Source": "ParameterIdentification",
                "Method": "ParameterIdentification",
                "Description": "Value updated from 'IV + Oral' on 2018-11-13 16:52"
              }
            }
          ]
        }
      ],
      "CalculationMethods": [
        "Cellular partition coefficient method - Rodgers and Rowland",
        "Cellular permeability - PK-Sim Standard"
      ],
      "Parameters": [
        {
          "Name": "Cl",
          "Value": 2.0
        },
        {
          "Name": "Molecular weight",
          "Value": 343.21,
          "Unit": "g/mol"
        }
      ]
    }
  ],
  "Formulations": [
    {
      "Name": "Oral solution",
      "FormulationType": "Formulation_Dissolved"
    },
    {
      "Name": "Halcion",
      "FormulationType": "Formulation_Tablet_Weibull",
      "Parameters": [
        {
          "Name": "Dissolution time (50% dissolved)",
          "Value": 1.7958147418,
          "Unit": "min",
          "ValueOrigin": {
            "Source": "ParameterIdentification",
            "Method": "ParameterIdentification",
            "Description": "Value updated from 'IV + Oral' on 2018-11-13 16:52"
          }
        },
        {
          "Name": "Lag time",
          "Value": 0.0,
          "Unit": "min"
        },
        {
          "Name": "Dissolution shape",
          "Value": 2.5169993312,
          "ValueOrigin": {
            "Source": "ParameterIdentification",
            "Method": "ParameterIdentification",
            "Description": "Value updated from 'IV + Oral' on 2018-11-13 16:52"
          }
        },
        {
          "Name": "Use as suspension",
          "Value": 1.0
        }
      ]
    }
  ],
  "Protocols": [
    {
      "Name": "Triazolam 0.5 mg SD PO",
      "ApplicationType": "Oral",
      "DosingInterval": "Single",
      "Parameters": [
        {
          "Name": "Start time",
          "Value": 0.0,
          "Unit": "h"
        },
        {
          "Name": "InputDose",
          "Value": 0.5,
          "Unit": "mg"
        },
        {
          "Name": "Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ]
    },
    {
      "Name": "Rifampicin 600 mg over 5 days",
      "ApplicationType": "Oral",
      "DosingInterval": "DI_24",
      "Parameters": [
        {
          "Name": "Start time",
          "Value": 0.0,
          "Unit": "h"
        },
        {
          "Name": "InputDose",
          "Value": 600.0,
          "Unit": "mg"
        },
        {
          "Name": "End time",
          "Value": 120.0,
          "Unit": "h",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Name": "Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ]
    },
    {
      "Name": "Triazolam 0.5 mg @ t=113h",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 0.5,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 113.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    }
  ],
  "Simulations": [
    {
      "Name": "Villikka 1997 - Triazolam control - 0.5 mg SD PO",
      "Model": "4Comp",
      "ObservedData": [
        "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 1 - Triazolam - PO - 0.5 mg - Plasma - indiv.",
        "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 10 - Triazolam - PO - 0.5 mg - Plasma - indiv.",
        "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 2 - Triazolam - PO - 0.5 mg - Plasma - indiv.",
        "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 3 - Triazolam - PO - 0.5 mg - Plasma - indiv.",
        "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 4 - Triazolam - PO - 0.5 mg - Plasma - indiv.",
        "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 5 - Triazolam - PO - 0.5 mg - Plasma - indiv.",
        "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 6 - Triazolam - PO - 0.5 mg - Plasma - indiv.",
        "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 7 - Triazolam - PO - 0.5 mg - Plasma - indiv.",
        "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 8 - Triazolam - PO - 0.5 mg - Plasma - indiv.",
        "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 9 - Triazolam - PO - 0.5 mg - Plasma - indiv.",
        "Villikka 1997 - Triazolam + placebo - Triazolam - PO - 0.5 mg - Plasma - agg. (n=10)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 24.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Triazolam 0.5 mg SD PO|Halcion|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Triazolam|P (interstitial->intracellular)",
          "Value": 0.00015477761992,
          "Unit": "cm/min",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Triazolam|P (intracellular->interstitial)",
          "Value": 0.00015477761992,
          "Unit": "cm/min",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Triazolam|P (interstitial->intracellular)",
          "Value": 0.00015477761992,
          "Unit": "cm/min",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Triazolam|P (intracellular->interstitial)",
          "Value": 0.00015477761992,
          "Unit": "cm/min",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Triazolam|P (interstitial->intracellular)",
          "Value": 0.00015477761992,
          "Unit": "cm/min",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Triazolam|P (intracellular->interstitial)",
          "Value": 0.00015477761992,
          "Unit": "cm/min",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Triazolam|P (interstitial->intracellular)",
          "Value": 0.00015477761992,
          "Unit": "cm/min",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Triazolam|P (intracellular->interstitial)",
          "Value": 0.00015477761992,
          "Unit": "cm/min",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Triazolam|P (interstitial->intracellular)",
          "Value": 0.00015477761992,
          "Unit": "cm/min",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Triazolam|P (intracellular->interstitial)",
          "Value": 0.00015477761992,
          "Unit": "cm/min",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Triazolam|P (interstitial->intracellular)",
          "Value": 0.00015477761992,
          "Unit": "cm/min",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Triazolam|P (intracellular->interstitial)",
          "Value": 0.00015477761992,
          "Unit": "cm/min",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Triazolam|P (interstitial->intracellular)",
          "Value": 0.00015477761992,
          "Unit": "cm/min",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Triazolam|P (intracellular->interstitial)",
          "Value": 0.00015477761992,
          "Unit": "cm/min",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Triazolam|P (interstitial->intracellular)",
          "Value": 0.00015477761992,
          "Unit": "cm/min",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Triazolam|P (intracellular->interstitial)",
          "Value": 0.00015477761992,
          "Unit": "cm/min",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Triazolam|P (interstitial->intracellular)",
          "Value": 0.00015477761992,
          "Unit": "cm/min",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Triazolam|P (intracellular->interstitial)",
          "Value": 0.00015477761992,
          "Unit": "cm/min",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Triazolam|P (interstitial->intracellular)",
          "Value": 0.00015477761992,
          "Unit": "cm/min",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Triazolam|P (intracellular->interstitial)",
          "Value": 0.00015477761992,
          "Unit": "cm/min",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Triazolam|P (interstitial->intracellular)",
          "Value": 0.00015477761992,
          "Unit": "cm/min",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Triazolam|P (intracellular->interstitial)",
          "Value": 0.00015477761992,
          "Unit": "cm/min",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Triazolam|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h) - Villikka 1997",
      "Compounds": [
        {
          "Name": "Triazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-alpha-OH pathway",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "CYP3A4-4-OH pathway",
              "MoleculeName": "CYP3A4"
            }
          ],
          "Protocol": {
            "Name": "Triazolam 0.5 mg SD PO",
            "Formulations": [
              {
                "Name": "Halcion",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Villikka 1997 - Triazolam control - 0.5 mg SD PO-Triazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Villikka 1997 - Triazolam control - 0.5 mg SD PO|Organism|PeripheralVenousBlood|Triazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 1 - Triazolam - PO - 0.5 mg - Plasma - indiv.-Triazolam-Peripheral Venous Blood-Plasma-Individual",
              "X": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 1 - Triazolam - PO - 0.5 mg - Plasma - indiv.|Time",
              "Y": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 1 - Triazolam - PO - 0.5 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Triazolam|Individual",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 10 - Triazolam - PO - 0.5 mg - Plasma - indiv.-Triazolam-Peripheral Venous Blood-Plasma-Individual",
              "X": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 10 - Triazolam - PO - 0.5 mg - Plasma - indiv.|Time",
              "Y": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 10 - Triazolam - PO - 0.5 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Triazolam|Individual",
              "CurveOptions": {
                "Color": "#008000",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 2 - Triazolam - PO - 0.5 mg - Plasma - indiv.-Triazolam-Peripheral Venous Blood-Plasma-Individual",
              "X": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 2 - Triazolam - PO - 0.5 mg - Plasma - indiv.|Time",
              "Y": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 2 - Triazolam - PO - 0.5 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Triazolam|Individual",
              "CurveOptions": {
                "Color": "#FF00FF",
                "LegendIndex": 4,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 3 - Triazolam - PO - 0.5 mg - Plasma - indiv.-Triazolam-Peripheral Venous Blood-Plasma-Individual",
              "X": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 3 - Triazolam - PO - 0.5 mg - Plasma - indiv.|Time",
              "Y": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 3 - Triazolam - PO - 0.5 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Triazolam|Individual",
              "CurveOptions": {
                "Color": "#FF8000",
                "LegendIndex": 5,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 4 - Triazolam - PO - 0.5 mg - Plasma - indiv.-Triazolam-Peripheral Venous Blood-Plasma-Individual",
              "X": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 4 - Triazolam - PO - 0.5 mg - Plasma - indiv.|Time",
              "Y": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 4 - Triazolam - PO - 0.5 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Triazolam|Individual",
              "CurveOptions": {
                "Color": "#00C0C0",
                "LegendIndex": 6,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 5 - Triazolam - PO - 0.5 mg - Plasma - indiv.-Triazolam-Peripheral Venous Blood-Plasma-Individual",
              "X": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 5 - Triazolam - PO - 0.5 mg - Plasma - indiv.|Time",
              "Y": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 5 - Triazolam - PO - 0.5 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Triazolam|Individual",
              "CurveOptions": {
                "Color": "#C000C0",
                "LegendIndex": 7,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 6 - Triazolam - PO - 0.5 mg - Plasma - indiv.-Triazolam-Peripheral Venous Blood-Plasma-Individual",
              "X": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 6 - Triazolam - PO - 0.5 mg - Plasma - indiv.|Time",
              "Y": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 6 - Triazolam - PO - 0.5 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Triazolam|Individual",
              "CurveOptions": {
                "Color": "#C04000",
                "LegendIndex": 8,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 7 - Triazolam - PO - 0.5 mg - Plasma - indiv.-Triazolam-Peripheral Venous Blood-Plasma-Individual",
              "X": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 7 - Triazolam - PO - 0.5 mg - Plasma - indiv.|Time",
              "Y": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 7 - Triazolam - PO - 0.5 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Triazolam|Individual",
              "CurveOptions": {
                "Color": "#00FF00",
                "LegendIndex": 9,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 8 - Triazolam - PO - 0.5 mg - Plasma - indiv.-Triazolam-Peripheral Venous Blood-Plasma-Individual",
              "X": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 8 - Triazolam - PO - 0.5 mg - Plasma - indiv.|Time",
              "Y": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 8 - Triazolam - PO - 0.5 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Triazolam|Individual",
              "CurveOptions": {
                "Color": "#808080",
                "LegendIndex": 10,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 9 - Triazolam - PO - 0.5 mg - Plasma - indiv.-Triazolam-Peripheral Venous Blood-Plasma-Individual",
              "X": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 9 - Triazolam - PO - 0.5 mg - Plasma - indiv.|Time",
              "Y": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 9 - Triazolam - PO - 0.5 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Triazolam|Individual",
              "CurveOptions": {
                "Color": "#C0C000",
                "LegendIndex": 11,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Villikka 1997 - Triazolam + placebo - Triazolam - PO - 0.5 mg - Plasma - agg. (n=10)-Triazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Villikka 1997 - Triazolam + placebo - Triazolam - PO - 0.5 mg - Plasma - agg. (n=10)|Time",
              "Y": "Villikka 1997 - Triazolam + placebo - Triazolam - PO - 0.5 mg - Plasma - agg. (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Triazolam|ArithmeticMean",
              "CurveOptions": {
                "Color": "#000000",
                "LegendIndex": 12,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Rifampicin-Triazolam-DDI\nVillikka 1997 - Triazolam control - 0.5 mg SD PO\n2019-11-29 10:40"
        }
      ]
    },
    {
      "Name": "Villikka 1997 - Rifampicin 600 mg over 5 days and Triazolam 0.5 mg SD PO",
      "Model": "4Comp",
      "ObservedData": [
        "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days) - Triazolam - PO - 0.5 mg - Plasma - agg. (n=10)",
        "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 1 - Triazolam - PO - 0.5 mg - Plasma - indiv.",
        "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 10 - Triazolam - PO - 0.5 mg - Plasma - indiv.",
        "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 2 - Triazolam - PO - 0.5 mg - Plasma - indiv.",
        "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 3 - Triazolam - PO - 0.5 mg - Plasma - indiv.",
        "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 4 - Triazolam - PO - 0.5 mg - Plasma - indiv.",
        "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 5 - Triazolam - PO - 0.5 mg - Plasma - indiv.",
        "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 6 - Triazolam - PO - 0.5 mg - Plasma - indiv.",
        "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 7 - Triazolam - PO - 0.5 mg - Plasma - indiv.",
        "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 8 - Triazolam - PO - 0.5 mg - Plasma - indiv.",
        "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 9 - Triazolam - PO - 0.5 mg - Plasma - indiv."
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 112.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 112.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 114.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 114.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 120.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Rifampicin 600 mg over 5 days|Oral solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Rifampicin 600 mg over 5 days|Oral solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Rifampicin 600 mg over 5 days|Oral solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Rifampicin 600 mg over 5 days|Oral solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Rifampicin 600 mg over 5 days|Oral solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Triazolam 0.5 mg @ t=113h|Halcion|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Triazolam|P (interstitial->intracellular)",
          "Value": 0.00015477761992,
          "Unit": "cm/min",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Triazolam|P (intracellular->interstitial)",
          "Value": 0.00015477761992,
          "Unit": "cm/min",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Triazolam|P (interstitial->intracellular)",
          "Value": 0.00015477761992,
          "Unit": "cm/min",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Triazolam|P (intracellular->interstitial)",
          "Value": 0.00015477761992,
          "Unit": "cm/min",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Triazolam|P (interstitial->intracellular)",
          "Value": 0.00015477761992,
          "Unit": "cm/min",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Triazolam|P (intracellular->interstitial)",
          "Value": 0.00015477761992,
          "Unit": "cm/min",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Triazolam|P (interstitial->intracellular)",
          "Value": 0.00015477761992,
          "Unit": "cm/min",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Triazolam|P (intracellular->interstitial)",
          "Value": 0.00015477761992,
          "Unit": "cm/min",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Triazolam|P (interstitial->intracellular)",
          "Value": 0.00015477761992,
          "Unit": "cm/min",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Triazolam|P (intracellular->interstitial)",
          "Value": 0.00015477761992,
          "Unit": "cm/min",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Triazolam|P (interstitial->intracellular)",
          "Value": 0.00015477761992,
          "Unit": "cm/min",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Triazolam|P (intracellular->interstitial)",
          "Value": 0.00015477761992,
          "Unit": "cm/min",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Triazolam|P (interstitial->intracellular)",
          "Value": 0.00015477761992,
          "Unit": "cm/min",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Triazolam|P (intracellular->interstitial)",
          "Value": 0.00015477761992,
          "Unit": "cm/min",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Triazolam|P (interstitial->intracellular)",
          "Value": 0.00015477761992,
          "Unit": "cm/min",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Triazolam|P (intracellular->interstitial)",
          "Value": 0.00015477761992,
          "Unit": "cm/min",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Triazolam|P (interstitial->intracellular)",
          "Value": 0.00015477761992,
          "Unit": "cm/min",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Triazolam|P (intracellular->interstitial)",
          "Value": 0.00015477761992,
          "Unit": "cm/min",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Triazolam|P (interstitial->intracellular)",
          "Value": 0.00015477761992,
          "Unit": "cm/min",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Triazolam|P (intracellular->interstitial)",
          "Value": 0.00015477761992,
          "Unit": "cm/min",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Triazolam|P (interstitial->intracellular)",
          "Value": 0.00015477761992,
          "Unit": "cm/min",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        },
        {
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Triazolam|P (intracellular->interstitial)",
          "Value": 0.00015477761992,
          "Unit": "cm/min",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Triazolam|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "European (P-gp modified, CYP3A4 36 h) - Villikka 1997",
      "Compounds": [
        {
          "Name": "Triazolam",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-alpha-OH pathway",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "CYP3A4-4-OH pathway",
              "MoleculeName": "CYP3A4"
            }
          ],
          "Protocol": {
            "Name": "Triazolam 0.5 mg @ t=113h",
            "Formulations": [
              {
                "Name": "Halcion",
                "Key": "Formulation"
              }
            ]
          }
        },
        {
          "Name": "Rifampicin",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Aqueous solubility",
              "GroupName": "COMPOUND_SOLUBILITY"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Templeton 2011",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "AADAC-Nakajima 2011",
              "MoleculeName": "AADAC"
            },
            {
              "Name": "P-gp-Collett 2004",
              "MoleculeName": "P-gp"
            },
            {
              "Name": "OATP1B1-Tirona 2003",
              "MoleculeName": "OATP1B1"
            },
            {
              "Name": "Glomerular Filtration-GFR"
            }
          ],
          "Protocol": {
            "Name": "Rifampicin 600 mg over 5 days",
            "Formulations": [
              {
                "Name": "Oral solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "Min": 110.4814,
              "Max": 122.917,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": 1.011788E-07,
              "Max": 0.738142,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Villikka 1997 - Rifampicin 600 mg over 5 days and Triazolam 0.5 mg SD PO-Triazolam-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Villikka 1997 - Rifampicin 600 mg over 5 days and Triazolam 0.5 mg SD PO|Organism|PeripheralVenousBlood|Triazolam|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Villikka 1997 - Rifampicin 600 mg over 5 days and Triazolam 0.5 mg SD PO-Rifampicin-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Villikka 1997 - Rifampicin 600 mg over 5 days and Triazolam 0.5 mg SD PO|Organism|PeripheralVenousBlood|Rifampicin|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2
              }
            },
            {
              "Name": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days) - Triazolam - PO - 0.5 mg - Plasma - agg. (n=10)-Triazolam-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days) - Triazolam - PO - 0.5 mg - Plasma - agg. (n=10)|Time",
              "Y": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days) - Triazolam - PO - 0.5 mg - Plasma - agg. (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Triazolam|ArithmeticMean",
              "CurveOptions": {
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 1 - Triazolam - PO - 0.5 mg - Plasma - indiv.-Triazolam-Peripheral Venous Blood-Plasma-Individual",
              "X": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 1 - Triazolam - PO - 0.5 mg - Plasma - indiv.|Time",
              "Y": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 1 - Triazolam - PO - 0.5 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Triazolam|Individual",
              "CurveOptions": {
                "Color": "#FF00FF",
                "LegendIndex": 4,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 10 - Triazolam - PO - 0.5 mg - Plasma - indiv.-Triazolam-Peripheral Venous Blood-Plasma-Individual",
              "X": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 10 - Triazolam - PO - 0.5 mg - Plasma - indiv.|Time",
              "Y": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 10 - Triazolam - PO - 0.5 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Triazolam|Individual",
              "CurveOptions": {
                "Color": "#FF8000",
                "LegendIndex": 5,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 2 - Triazolam - PO - 0.5 mg - Plasma - indiv.-Triazolam-Peripheral Venous Blood-Plasma-Individual",
              "X": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 2 - Triazolam - PO - 0.5 mg - Plasma - indiv.|Time",
              "Y": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 2 - Triazolam - PO - 0.5 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Triazolam|Individual",
              "CurveOptions": {
                "Color": "#00C0C0",
                "LegendIndex": 6,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 3 - Triazolam - PO - 0.5 mg - Plasma - indiv.-Triazolam-Peripheral Venous Blood-Plasma-Individual",
              "X": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 3 - Triazolam - PO - 0.5 mg - Plasma - indiv.|Time",
              "Y": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 3 - Triazolam - PO - 0.5 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Triazolam|Individual",
              "CurveOptions": {
                "Color": "#C000C0",
                "LegendIndex": 7,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 4 - Triazolam - PO - 0.5 mg - Plasma - indiv.-Triazolam-Peripheral Venous Blood-Plasma-Individual",
              "X": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 4 - Triazolam - PO - 0.5 mg - Plasma - indiv.|Time",
              "Y": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 4 - Triazolam - PO - 0.5 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Triazolam|Individual",
              "CurveOptions": {
                "Color": "#C04000",
                "LegendIndex": 8,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 5 - Triazolam - PO - 0.5 mg - Plasma - indiv.-Triazolam-Peripheral Venous Blood-Plasma-Individual",
              "X": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 5 - Triazolam - PO - 0.5 mg - Plasma - indiv.|Time",
              "Y": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 5 - Triazolam - PO - 0.5 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Triazolam|Individual",
              "CurveOptions": {
                "Color": "#00FF00",
                "LegendIndex": 9,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 6 - Triazolam - PO - 0.5 mg - Plasma - indiv.-Triazolam-Peripheral Venous Blood-Plasma-Individual",
              "X": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 6 - Triazolam - PO - 0.5 mg - Plasma - indiv.|Time",
              "Y": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 6 - Triazolam - PO - 0.5 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Triazolam|Individual",
              "CurveOptions": {
                "Color": "#808080",
                "LegendIndex": 10,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 7 - Triazolam - PO - 0.5 mg - Plasma - indiv.-Triazolam-Peripheral Venous Blood-Plasma-Individual",
              "X": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 7 - Triazolam - PO - 0.5 mg - Plasma - indiv.|Time",
              "Y": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 7 - Triazolam - PO - 0.5 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Triazolam|Individual",
              "CurveOptions": {
                "Color": "#C0C000",
                "LegendIndex": 11,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 8 - Triazolam - PO - 0.5 mg - Plasma - indiv.-Triazolam-Peripheral Venous Blood-Plasma-Individual",
              "X": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 8 - Triazolam - PO - 0.5 mg - Plasma - indiv.|Time",
              "Y": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 8 - Triazolam - PO - 0.5 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Triazolam|Individual",
              "CurveOptions": {
                "Color": "#8080FF",
                "LegendIndex": 12,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 9 - Triazolam - PO - 0.5 mg - Plasma - indiv.-Triazolam-Peripheral Venous Blood-Plasma-Individual",
              "X": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 9 - Triazolam - PO - 0.5 mg - Plasma - indiv.|Time",
              "Y": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 9 - Triazolam - PO - 0.5 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Triazolam|Individual",
              "CurveOptions": {
                "Color": "#0000C0",
                "LegendIndex": 13,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Rifampicin-Triazolam-DDI\nVillikka 1997 - Rifampicin 600 mg over 5 days + Triazolam 0.5 mg SD PO\n2019-11-29 10:41"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Kajosaari 2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Reitman 2011",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "CYP3A4-Templeton 2011",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "AADAC-Assumed",
          "MoleculeName": "AADAC",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "P-gp-Greiner 1999",
          "MoleculeName": "P-gp",
          "CompoundName": "Rifampicin"
        },
        {
          "Name": "OATP1B1-Dixit 2007",
          "MoleculeName": "OATP1B1",
          "CompoundName": "Rifampicin"
        }
      ]
    }
  ],
  "ObservedData": [
    {
      "Name": "Villikka 1997 - Triazolam + placebo - Triazolam - PO - 0.5 mg - Plasma - agg. (n=10)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 726.0
        },
        {
          "Name": "Study Id",
          "Value": "Villikka 1997"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/9024169"
        },
        {
          "Name": "Source",
          "Value": "Fig. 1"
        },
        {
          "Name": "Grouping",
          "Value": "Triazolam + placebo"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 10.0
        },
        {
          "Name": "Molecule",
          "Value": "Triazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "0.5 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "Halcion®"
        },
        {
          "Name": "Food state",
          "Value": "Fasted"
        },
        {
          "Name": "Comment",
          "Value": "Arith. SEM converted to arith. SD"
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Name": "Var",
                "Path": "Villikka 1997 - Triazolam + placebo - Triazolam - PO - 0.5 mg - Plasma - agg. (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Triazolam|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "Date": "0001-01-01T00:00:00",
                "MolWeight": 343.21
              },
              "Values": [
                0.000826565665,
                0.001200524,
                0.00118075975,
                0.0007676808,
                0.00072840217,
                0.00051173236,
                0.0003346765,
                0.000255948427,
                "NaN",
                "NaN"
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Villikka 1997 - Triazolam + placebo - Triazolam - PO - 0.5 mg - Plasma - agg. (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Triazolam|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 343.21,
            "LLOQ": 5E-11
          },
          "Values": [
            0.0008346363,
            0.001924509,
            0.002373282,
            0.00250460487,
            0.002294199,
            0.00177886907,
            0.00136926991,
            0.00109665,
            0.000657219731,
            0.0003796648
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Villikka 1997 - Triazolam + placebo - Triazolam - PO - 0.5 mg - Plasma - agg. (n=10)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          0.5,
          1.0,
          1.5,
          2.0,
          3.0,
          4.0,
          5.0,
          6.0,
          8.0,
          10.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days) - Triazolam - PO - 0.5 mg - Plasma - agg. (n=10)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 1004.0
        },
        {
          "Name": "Study Id",
          "Value": "Villikka 1997"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/9024169"
        },
        {
          "Name": "Source",
          "Value": "Fig. 1; Table I"
        },
        {
          "Name": "Grouping",
          "Value": "Treatment arm (pretreatment with rifampin; 600 mg; 5 days)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 10.0
        },
        {
          "Name": "Molecule",
          "Value": "Triazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "0.5 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 113.0
        },
        {
          "Name": "Formulation",
          "Value": "Halcion 0.25 mg tablets, Upjohn, Kalamazoo, Mich."
        },
        {
          "Name": "Food state",
          "Value": "fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days) - Triazolam - PO - 0.5 mg - Plasma - agg. (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Triazolam|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 343.21,
            "LLOQ": 5E-11
          },
          "Values": [
            0.0001082591,
            0.0002365623,
            0.0002646447,
            0.0002459575,
            0.000155073,
            7.755124E-05,
            5.34215724E-05
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days) - Triazolam - PO - 0.5 mg - Plasma - agg. (n=10)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          113.5,
          114.0,
          114.5,
          115.0,
          116.0,
          117.0,
          118.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 1 - Triazolam - PO - 0.5 mg - Plasma - indiv.",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 1005.0
        },
        {
          "Name": "Study Id",
          "Value": "Villikka 1997"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/9024169"
        },
        {
          "Name": "Source",
          "Value": "Fig. 2"
        },
        {
          "Name": "Grouping",
          "Value": "Control arm (pretreatment with placebo for 5 days); Subject 1"
        },
        {
          "Name": "Data type",
          "Value": "individual"
        },
        {
          "Name": "N",
          "Value": 1.0
        },
        {
          "Name": "Molecule",
          "Value": "Triazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "0.5 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "Halcion 0.25 mg tablets, Upjohn, Kalamazoo, Mich."
        },
        {
          "Name": "Food state",
          "Value": "fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 1 - Triazolam - PO - 0.5 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Triazolam|Individual"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 343.21,
            "LLOQ": 5E-11
          },
          "Values": [
            0.001250828,
            0.002932953,
            0.00254747,
            0.002598635,
            0.002175267,
            0.00149294094,
            0.001226256,
            0.0009699315,
            0.000790654449,
            0.000341988285
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 1 - Triazolam - PO - 0.5 mg - Plasma - indiv.|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          0.5,
          1.0,
          1.5,
          2.0,
          3.0,
          4.0,
          5.0,
          6.0,
          8.0,
          10.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 2 - Triazolam - PO - 0.5 mg - Plasma - indiv.",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 1006.0
        },
        {
          "Name": "Study Id",
          "Value": "Villikka 1997"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/9024169"
        },
        {
          "Name": "Source",
          "Value": "Fig. 2"
        },
        {
          "Name": "Grouping",
          "Value": "Control arm (pretreatment with placebo for 5 days); Subject 2"
        },
        {
          "Name": "Data type",
          "Value": "individual"
        },
        {
          "Name": "N",
          "Value": 1.0
        },
        {
          "Name": "Molecule",
          "Value": "Triazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "0.5 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "Halcion 0.25 mg tablets, Upjohn, Kalamazoo, Mich."
        },
        {
          "Name": "Food state",
          "Value": "fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 2 - Triazolam - PO - 0.5 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Triazolam|Individual"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 343.21,
            "LLOQ": 5E-11
          },
          "Values": [
            0.00121156091,
            0.002792349,
            0.00298545021,
            0.00271654688,
            0.002186332,
            0.001694059,
            0.00128794508,
            0.001036549,
            0.0005823606,
            0.000336637575
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 2 - Triazolam - PO - 0.5 mg - Plasma - indiv.|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          0.5,
          1.0,
          1.5,
          2.0,
          3.0,
          4.0,
          5.0,
          6.0,
          8.0,
          10.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 3 - Triazolam - PO - 0.5 mg - Plasma - indiv.",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 1007.0
        },
        {
          "Name": "Study Id",
          "Value": "Villikka 1997"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/9024169"
        },
        {
          "Name": "Source",
          "Value": "Fig. 2"
        },
        {
          "Name": "Grouping",
          "Value": "Control arm (pretreatment with placebo for 5 days); Subject 3"
        },
        {
          "Name": "Data type",
          "Value": "individual"
        },
        {
          "Name": "N",
          "Value": 1.0
        },
        {
          "Name": "Molecule",
          "Value": "Triazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "0.5 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "Halcion 0.25 mg tablets, Upjohn, Kalamazoo, Mich."
        },
        {
          "Name": "Food state",
          "Value": "fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 3 - Triazolam - PO - 0.5 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Triazolam|Individual"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 343.21,
            "LLOQ": 5E-11
          },
          "Values": [
            0.0001000969,
            0.00118291611,
            0.003257811,
            0.002938655,
            0.00239115115,
            0.001945654,
            0.00153886608,
            0.00126402,
            0.0007261542,
            0.0004132341
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 3 - Triazolam - PO - 0.5 mg - Plasma - indiv.|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          0.5,
          1.0,
          1.5,
          2.0,
          3.0,
          4.0,
          5.0,
          6.0,
          8.0,
          10.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 4 - Triazolam - PO - 0.5 mg - Plasma - indiv.",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 1008.0
        },
        {
          "Name": "Study Id",
          "Value": "Villikka 1997"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/9024169"
        },
        {
          "Name": "Source",
          "Value": "Fig. 2"
        },
        {
          "Name": "Grouping",
          "Value": "Control arm (pretreatment with placebo for 5 days); Subject 4"
        },
        {
          "Name": "Data type",
          "Value": "individual"
        },
        {
          "Name": "N",
          "Value": 1.0
        },
        {
          "Name": "Molecule",
          "Value": "Triazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "0.5 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "Halcion 0.25 mg tablets, Upjohn, Kalamazoo, Mich."
        },
        {
          "Name": "Food state",
          "Value": "fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 4 - Triazolam - PO - 0.5 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Triazolam|Individual"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 343.21,
            "LLOQ": 5E-11
          },
          "Values": [
            0.0003966564,
            0.00134019612,
            0.00190098293,
            0.001901874,
            0.001576315,
            0.00133137,
            0.001072675,
            0.0009587703,
            0.0006050269,
            0.0004316181
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 4 - Triazolam - PO - 0.5 mg - Plasma - indiv.|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          0.5,
          1.0,
          1.5,
          2.0,
          3.0,
          4.0,
          5.0,
          6.0,
          8.0,
          10.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 5 - Triazolam - PO - 0.5 mg - Plasma - indiv.",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 1009.0
        },
        {
          "Name": "Study Id",
          "Value": "Villikka 1997"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/9024169"
        },
        {
          "Name": "Source",
          "Value": "Fig. 2"
        },
        {
          "Name": "Grouping",
          "Value": "Control arm (pretreatment with placebo for 5 days); Subject 5"
        },
        {
          "Name": "Data type",
          "Value": "individual"
        },
        {
          "Name": "N",
          "Value": 1.0
        },
        {
          "Name": "Molecule",
          "Value": "Triazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "0.5 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "Halcion 0.25 mg tablets, Upjohn, Kalamazoo, Mich."
        },
        {
          "Name": "Food state",
          "Value": "fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 5 - Triazolam - PO - 0.5 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Triazolam|Individual"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 343.21,
            "LLOQ": 5E-11
          },
          "Values": [
            0.00265759113,
            0.003574548,
            0.003752604,
            0.00325593,
            0.00257050712,
            0.001953395,
            0.001375487,
            0.001075657,
            0.000633134448,
            0.0003621474
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 5 - Triazolam - PO - 0.5 mg - Plasma - indiv.|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          0.5,
          1.0,
          1.5,
          2.0,
          3.0,
          4.0,
          5.0,
          6.0,
          8.0,
          10.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 6 - Triazolam - PO - 0.5 mg - Plasma - indiv.",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 1010.0
        },
        {
          "Name": "Study Id",
          "Value": "Villikka 1997"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/9024169"
        },
        {
          "Name": "Source",
          "Value": "Fig. 2"
        },
        {
          "Name": "Grouping",
          "Value": "Control arm (pretreatment with placebo for 5 days); Subject 6"
        },
        {
          "Name": "Data type",
          "Value": "individual"
        },
        {
          "Name": "N",
          "Value": 1.0
        },
        {
          "Name": "Molecule",
          "Value": "Triazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "0.5 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "Halcion 0.25 mg tablets, Upjohn, Kalamazoo, Mich."
        },
        {
          "Name": "Food state",
          "Value": "fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 6 - Triazolam - PO - 0.5 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Triazolam|Individual"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 343.21,
            "LLOQ": 5E-11
          },
          "Values": [
            0.001258954,
            0.003161577,
            0.003286896,
            0.002853853,
            0.002234515,
            0.00181711407,
            0.001520371,
            0.001224738,
            0.000757993,
            0.0004691233
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 6 - Triazolam - PO - 0.5 mg - Plasma - indiv.|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          0.5,
          1.0,
          1.5,
          2.0,
          3.0,
          4.0,
          5.0,
          6.0,
          8.0,
          10.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 7 - Triazolam - PO - 0.5 mg - Plasma - indiv.",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 1011.0
        },
        {
          "Name": "Study Id",
          "Value": "Villikka 1997"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/9024169"
        },
        {
          "Name": "Source",
          "Value": "Fig. 2"
        },
        {
          "Name": "Grouping",
          "Value": "Control arm (pretreatment with placebo for 5 days); Subject 7"
        },
        {
          "Name": "Data type",
          "Value": "individual"
        },
        {
          "Name": "N",
          "Value": 1.0
        },
        {
          "Name": "Molecule",
          "Value": "Triazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "0.5 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "Halcion 0.25 mg tablets, Upjohn, Kalamazoo, Mich."
        },
        {
          "Name": "Food state",
          "Value": "fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 7 - Triazolam - PO - 0.5 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Triazolam|Individual"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 343.21,
            "LLOQ": 5E-11
          },
          "Values": [
            0.000143654,
            0.000295622274,
            0.0008723041,
            0.0014863339,
            0.001329012,
            0.001070662,
            0.000862455,
            0.000485447119,
            0.000283814181
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 7 - Triazolam - PO - 0.5 mg - Plasma - indiv.|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          1.0,
          1.5,
          2.0,
          3.0,
          4.0,
          5.0,
          6.0,
          8.0,
          10.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 8 - Triazolam - PO - 0.5 mg - Plasma - indiv.",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 1012.0
        },
        {
          "Name": "Study Id",
          "Value": "Villikka 1997"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/9024169"
        },
        {
          "Name": "Source",
          "Value": "Fig. 2"
        },
        {
          "Name": "Grouping",
          "Value": "Control arm (pretreatment with placebo for 5 days); Subject 8"
        },
        {
          "Name": "Data type",
          "Value": "individual"
        },
        {
          "Name": "N",
          "Value": 1.0
        },
        {
          "Name": "Molecule",
          "Value": "Triazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "0.5 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "Halcion 0.25 mg tablets, Upjohn, Kalamazoo, Mich."
        },
        {
          "Name": "Food state",
          "Value": "fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 8 - Triazolam - PO - 0.5 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Triazolam|Individual"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 343.21,
            "LLOQ": 5E-11
          },
          "Values": [
            8.856282E-05,
            0.001401279,
            0.002941737,
            0.003495846,
            0.00319155585,
            0.00225570286,
            0.001769339,
            0.001401152,
            0.000769581646,
            0.000395496376
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 8 - Triazolam - PO - 0.5 mg - Plasma - indiv.|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          0.5,
          1.0,
          1.5,
          2.0,
          3.0,
          4.0,
          5.0,
          6.0,
          8.0,
          10.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 9 - Triazolam - PO - 0.5 mg - Plasma - indiv.",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 1013.0
        },
        {
          "Name": "Study Id",
          "Value": "Villikka 1997"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/9024169"
        },
        {
          "Name": "Source",
          "Value": "Fig. 2"
        },
        {
          "Name": "Grouping",
          "Value": "Control arm (pretreatment with placebo for 5 days); Subject 9"
        },
        {
          "Name": "Data type",
          "Value": "individual"
        },
        {
          "Name": "N",
          "Value": 1.0
        },
        {
          "Name": "Molecule",
          "Value": "Triazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "0.5 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "Halcion 0.25 mg tablets, Upjohn, Kalamazoo, Mich."
        },
        {
          "Name": "Food state",
          "Value": "fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 9 - Triazolam - PO - 0.5 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Triazolam|Individual"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 343.21,
            "LLOQ": 5E-11
          },
          "Values": [
            0.0001296909,
            0.0003100315,
            0.000429846725,
            0.00252337987,
            0.00371254981,
            0.00287955184,
            0.001991353,
            0.001559185,
            0.0008124865,
            0.0005028808
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 9 - Triazolam - PO - 0.5 mg - Plasma - indiv.|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          0.5,
          1.0,
          1.5,
          2.0,
          3.0,
          4.0,
          5.0,
          6.0,
          8.0,
          10.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 10 - Triazolam - PO - 0.5 mg - Plasma - indiv.",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 1014.0
        },
        {
          "Name": "Study Id",
          "Value": "Villikka 1997"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/9024169"
        },
        {
          "Name": "Source",
          "Value": "Fig. 2"
        },
        {
          "Name": "Grouping",
          "Value": "Control arm (pretreatment with placebo for 5 days); Subject 10"
        },
        {
          "Name": "Data type",
          "Value": "individual"
        },
        {
          "Name": "N",
          "Value": 1.0
        },
        {
          "Name": "Molecule",
          "Value": "Triazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "0.5 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "Halcion 0.25 mg tablets, Upjohn, Kalamazoo, Mich."
        },
        {
          "Name": "Food state",
          "Value": "fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 10 - Triazolam - PO - 0.5 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Triazolam|Individual"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 343.21,
            "LLOQ": 5E-11
          },
          "Values": [
            0.001264764,
            0.00233224872,
            0.002249545,
            0.00188035215,
            0.001473096,
            0.001198897,
            0.000912812131,
            0.0007719173,
            0.000447476079,
            0.000259431225
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Villikka 1997 - Control arm (pretreatment with placebo for 5 days); Subject 10 - Triazolam - PO - 0.5 mg - Plasma - indiv.|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          0.5,
          1.0,
          1.5,
          2.0,
          3.0,
          4.0,
          5.0,
          6.0,
          8.0,
          10.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 1 - Triazolam - PO - 0.5 mg - Plasma - indiv.",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 1015.0
        },
        {
          "Name": "Study Id",
          "Value": "Villikka 1997"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/9024169"
        },
        {
          "Name": "Source",
          "Value": "Fig. 2"
        },
        {
          "Name": "Grouping",
          "Value": "Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 1"
        },
        {
          "Name": "Data type",
          "Value": "individual"
        },
        {
          "Name": "N",
          "Value": 1.0
        },
        {
          "Name": "Molecule",
          "Value": "Triazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "0.5 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 113.0
        },
        {
          "Name": "Formulation",
          "Value": "Halcion 0.25 mg tablets, Upjohn, Kalamazoo, Mich."
        },
        {
          "Name": "Food state",
          "Value": "fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 1 - Triazolam - PO - 0.5 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Triazolam|Individual"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 343.21,
            "LLOQ": 5E-11
          },
          "Values": [
            9.02878746E-05,
            0.000129459091,
            0.0002584765,
            0.0001203702,
            7.10087E-05
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 1 - Triazolam - PO - 0.5 mg - Plasma - indiv.|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          114.0,
          114.5,
          115.0,
          116.0,
          117.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 2 - Triazolam - PO - 0.5 mg - Plasma - indiv.",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 1016.0
        },
        {
          "Name": "Study Id",
          "Value": "Villikka 1997"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/9024169"
        },
        {
          "Name": "Source",
          "Value": "Fig. 2"
        },
        {
          "Name": "Grouping",
          "Value": "Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 2"
        },
        {
          "Name": "Data type",
          "Value": "individual"
        },
        {
          "Name": "N",
          "Value": 1.0
        },
        {
          "Name": "Molecule",
          "Value": "Triazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "0.5 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 113.0
        },
        {
          "Name": "Formulation",
          "Value": "Halcion 0.25 mg tablets, Upjohn, Kalamazoo, Mich."
        },
        {
          "Name": "Food state",
          "Value": "fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 2 - Triazolam - PO - 0.5 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Triazolam|Individual"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 343.21,
            "LLOQ": 5E-11
          },
          "Values": [
            8.84420442E-05,
            0.000215771186,
            0.0002465258,
            0.000213939507,
            0.000147938918,
            0.0001093224,
            6.02086147E-05
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 2 - Triazolam - PO - 0.5 mg - Plasma - indiv.|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          113.5,
          114.0,
          114.5,
          115.0,
          116.0,
          117.0,
          118.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 3 - Triazolam - PO - 0.5 mg - Plasma - indiv.",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 1017.0
        },
        {
          "Name": "Study Id",
          "Value": "Villikka 1997"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/9024169"
        },
        {
          "Name": "Source",
          "Value": "Fig. 2"
        },
        {
          "Name": "Grouping",
          "Value": "Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 3"
        },
        {
          "Name": "Data type",
          "Value": "individual"
        },
        {
          "Name": "N",
          "Value": 1.0
        },
        {
          "Name": "Molecule",
          "Value": "Triazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "0.5 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 113.0
        },
        {
          "Name": "Formulation",
          "Value": "Halcion 0.25 mg tablets, Upjohn, Kalamazoo, Mich."
        },
        {
          "Name": "Food state",
          "Value": "fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 3 - Triazolam - PO - 0.5 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Triazolam|Individual"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 343.21,
            "LLOQ": 5E-11
          },
          "Values": [
            0.000118678596,
            0.0002604474,
            0.000510287,
            0.000717937131,
            0.0004440392,
            0.00022946141,
            0.0001208371,
            6.01271822E-05
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 3 - Triazolam - PO - 0.5 mg - Plasma - indiv.|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          113.5,
          114.0,
          114.5,
          115.0,
          116.0,
          117.0,
          118.0,
          119.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 4 - Triazolam - PO - 0.5 mg - Plasma - indiv.",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 1018.0
        },
        {
          "Name": "Study Id",
          "Value": "Villikka 1997"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/9024169"
        },
        {
          "Name": "Source",
          "Value": "Fig. 2"
        },
        {
          "Name": "Grouping",
          "Value": "Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 4"
        },
        {
          "Name": "Data type",
          "Value": "individual"
        },
        {
          "Name": "N",
          "Value": 1.0
        },
        {
          "Name": "Molecule",
          "Value": "Triazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "0.5 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 113.0
        },
        {
          "Name": "Formulation",
          "Value": "Halcion 0.25 mg tablets, Upjohn, Kalamazoo, Mich."
        },
        {
          "Name": "Food state",
          "Value": "fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 4 - Triazolam - PO - 0.5 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Triazolam|Individual"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 343.21,
            "LLOQ": 5E-11
          },
          "Values": [
            6.990473E-05,
            0.0003286035,
            0.000227552388,
            0.000160580108,
            0.000109171706,
            7.08014E-05
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 4 - Triazolam - PO - 0.5 mg - Plasma - indiv.|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          113.5,
          114.0,
          114.5,
          115.0,
          116.0,
          117.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 5 - Triazolam - PO - 0.5 mg - Plasma - indiv.",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 1019.0
        },
        {
          "Name": "Study Id",
          "Value": "Villikka 1997"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/9024169"
        },
        {
          "Name": "Source",
          "Value": "Fig. 2"
        },
        {
          "Name": "Grouping",
          "Value": "Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 5"
        },
        {
          "Name": "Data type",
          "Value": "individual"
        },
        {
          "Name": "N",
          "Value": 1.0
        },
        {
          "Name": "Molecule",
          "Value": "Triazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "0.5 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 113.0
        },
        {
          "Name": "Formulation",
          "Value": "Halcion 0.25 mg tablets, Upjohn, Kalamazoo, Mich."
        },
        {
          "Name": "Food state",
          "Value": "fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 5 - Triazolam - PO - 0.5 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Triazolam|Individual"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 343.21,
            "LLOQ": 5E-11
          },
          "Values": [
            0.000422591518,
            0.000270265,
            0.00016167901,
            9.9623714E-05
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 5 - Triazolam - PO - 0.5 mg - Plasma - indiv.|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          114.0,
          114.5,
          115.0,
          116.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 6 - Triazolam - PO - 0.5 mg - Plasma - indiv.",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 1020.0
        },
        {
          "Name": "Study Id",
          "Value": "Villikka 1997"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/9024169"
        },
        {
          "Name": "Source",
          "Value": "Fig. 2"
        },
        {
          "Name": "Grouping",
          "Value": "Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 6"
        },
        {
          "Name": "Data type",
          "Value": "individual"
        },
        {
          "Name": "N",
          "Value": 1.0
        },
        {
          "Name": "Molecule",
          "Value": "Triazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "0.5 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 113.0
        },
        {
          "Name": "Formulation",
          "Value": "Halcion 0.25 mg tablets, Upjohn, Kalamazoo, Mich."
        },
        {
          "Name": "Food state",
          "Value": "fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 6 - Triazolam - PO - 0.5 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Triazolam|Individual"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 343.21,
            "LLOQ": 5E-11
          },
          "Values": [
            0.0001718532,
            0.000140954711,
            8.864886E-05,
            6.014699E-05
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 6 - Triazolam - PO - 0.5 mg - Plasma - indiv.|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          113.5,
          114.0,
          114.5,
          115.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 7 - Triazolam - PO - 0.5 mg - Plasma - indiv.",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 1021.0
        },
        {
          "Name": "Study Id",
          "Value": "Villikka 1997"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/9024169"
        },
        {
          "Name": "Source",
          "Value": "Fig. 2"
        },
        {
          "Name": "Grouping",
          "Value": "Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 7"
        },
        {
          "Name": "Data type",
          "Value": "individual"
        },
        {
          "Name": "N",
          "Value": 1.0
        },
        {
          "Name": "Molecule",
          "Value": "Triazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "0.5 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 113.0
        },
        {
          "Name": "Formulation",
          "Value": "Halcion 0.25 mg tablets, Upjohn, Kalamazoo, Mich."
        },
        {
          "Name": "Food state",
          "Value": "fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 7 - Triazolam - PO - 0.5 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Triazolam|Individual"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 343.21,
            "LLOQ": 5E-11
          },
          "Values": [
            0.0001294243,
            0.0001705526,
            0.0001691076,
            0.0001005709,
            5.042865E-05
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 7 - Triazolam - PO - 0.5 mg - Plasma - indiv.|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          114.0,
          114.5,
          115.0,
          116.0,
          117.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 8 - Triazolam - PO - 0.5 mg - Plasma - indiv.",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 1022.0
        },
        {
          "Name": "Study Id",
          "Value": "Villikka 1997"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/9024169"
        },
        {
          "Name": "Source",
          "Value": "Fig. 2"
        },
        {
          "Name": "Grouping",
          "Value": "Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 8"
        },
        {
          "Name": "Data type",
          "Value": "individual"
        },
        {
          "Name": "N",
          "Value": 1.0
        },
        {
          "Name": "Molecule",
          "Value": "Triazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "0.5 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 113.0
        },
        {
          "Name": "Formulation",
          "Value": "Halcion 0.25 mg tablets, Upjohn, Kalamazoo, Mich."
        },
        {
          "Name": "Food state",
          "Value": "fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 8 - Triazolam - PO - 0.5 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Triazolam|Individual"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 343.21,
            "LLOQ": 5E-11
          },
          "Values": [
            0.0001968072,
            0.0002475711,
            0.000225610493,
            0.000147796789,
            7.93386062E-05,
            6.9732414E-05,
            5.957751E-05
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 8 - Triazolam - PO - 0.5 mg - Plasma - indiv.|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          114.0,
          114.5,
          115.0,
          116.0,
          117.0,
          118.0,
          119.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 9 - Triazolam - PO - 0.5 mg - Plasma - indiv.",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 1023.0
        },
        {
          "Name": "Study Id",
          "Value": "Villikka 1997"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/9024169"
        },
        {
          "Name": "Source",
          "Value": "Fig. 2"
        },
        {
          "Name": "Grouping",
          "Value": "Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 9"
        },
        {
          "Name": "Data type",
          "Value": "individual"
        },
        {
          "Name": "N",
          "Value": 1.0
        },
        {
          "Name": "Molecule",
          "Value": "Triazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "0.5 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 113.0
        },
        {
          "Name": "Formulation",
          "Value": "Halcion 0.25 mg tablets, Upjohn, Kalamazoo, Mich."
        },
        {
          "Name": "Food state",
          "Value": "fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 9 - Triazolam - PO - 0.5 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Triazolam|Individual"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 343.21,
            "LLOQ": 5E-11
          },
          "Values": [
            0.0005869697,
            0.0003862667,
            0.0002517418,
            0.000198622089,
            0.0001201419
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 9 - Triazolam - PO - 0.5 mg - Plasma - indiv.|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          113.5,
          114.0,
          114.5,
          115.0,
          116.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 10 - Triazolam - PO - 0.5 mg - Plasma - indiv.",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 1024.0
        },
        {
          "Name": "Study Id",
          "Value": "Villikka 1997"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/9024169"
        },
        {
          "Name": "Source",
          "Value": "Fig. 2"
        },
        {
          "Name": "Grouping",
          "Value": "Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 10"
        },
        {
          "Name": "Data type",
          "Value": "individual"
        },
        {
          "Name": "N",
          "Value": 1.0
        },
        {
          "Name": "Molecule",
          "Value": "Triazolam"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "0.5 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 113.0
        },
        {
          "Name": "Formulation",
          "Value": "Halcion 0.25 mg tablets, Upjohn, Kalamazoo, Mich."
        },
        {
          "Name": "Food state",
          "Value": "fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 10 - Triazolam - PO - 0.5 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Triazolam|Individual"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 343.21,
            "LLOQ": 5E-11
          },
          "Values": [
            8.86872658E-05,
            0.000393053284,
            0.0002445225,
            0.000128379892,
            7.067958E-05,
            5.131233E-05
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days); Subject 10 - Triazolam - PO - 0.5 mg - Plasma - indiv.|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          114.0,
          114.5,
          115.0,
          116.0,
          117.0,
          118.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    }
  ]
}